ES2426441T3 - Oligopéptidos y su uso en cosméticos - Google Patents

Oligopéptidos y su uso en cosméticos Download PDF

Info

Publication number
ES2426441T3
ES2426441T3 ES05798576T ES05798576T ES2426441T3 ES 2426441 T3 ES2426441 T3 ES 2426441T3 ES 05798576 T ES05798576 T ES 05798576T ES 05798576 T ES05798576 T ES 05798576T ES 2426441 T3 ES2426441 T3 ES 2426441T3
Authority
ES
Spain
Prior art keywords
group
saturated
pro
unsaturated
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05798576T
Other languages
English (en)
Spanish (es)
Inventor
Philippe Moussou
Louis Danoux
Gilles Pauly
Jean-Luc Contet-Audonneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
BASF Beauty Care Solutions France SAS
Original Assignee
BASF Beauty Care Solutions France SAS
Cognis France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Beauty Care Solutions France SAS, Cognis France SAS filed Critical BASF Beauty Care Solutions France SAS
Application granted granted Critical
Publication of ES2426441T3 publication Critical patent/ES2426441T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
ES05798576T 2004-10-18 2005-10-10 Oligopéptidos y su uso en cosméticos Expired - Lifetime ES2426441T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292475 2004-10-18
EP04292475 2004-10-18
PCT/EP2005/010893 WO2006042661A2 (en) 2004-10-18 2005-10-10 Oligopeptides and their use in cosmetics

Publications (1)

Publication Number Publication Date
ES2426441T3 true ES2426441T3 (es) 2013-10-23

Family

ID=34931464

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05798576T Expired - Lifetime ES2426441T3 (es) 2004-10-18 2005-10-10 Oligopéptidos y su uso en cosméticos

Country Status (6)

Country Link
US (2) US8044028B2 (enExample)
EP (1) EP1802655B1 (enExample)
JP (1) JP5159311B2 (enExample)
KR (1) KR101264441B1 (enExample)
ES (1) ES2426441T3 (enExample)
WO (1) WO2006042661A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006042661A2 (en) 2004-10-18 2006-04-27 Cognis France S.A.S Oligopeptides and their use in cosmetics
ATE533785T1 (de) * 2006-06-13 2011-12-15 Helix Biomedix Inc Peptidfragmente zur induzierung der synthese extrazellulärer matrixproteine
CN107028792A (zh) * 2008-05-29 2017-08-11 唐纳德·欧文 皮肤美容组合物中的寡聚生物表面活性剂
RU2411248C2 (ru) * 2008-11-13 2011-02-10 Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) Средство, обладающее антипсихотической активностью
MX2012003563A (es) 2009-09-24 2012-04-30 Unilever Nv Agente desinfectante que comprende eugenol, terpineol y timol.
KR20130059335A (ko) * 2010-04-07 2013-06-05 고쿠리츠 다이가쿠 호진 교토 다이가쿠 생리 활성 펩티드
CN103354741B (zh) 2010-12-07 2016-01-13 荷兰联合利华有限公司 口腔护理组合物
WO2013064360A2 (en) 2011-11-03 2013-05-10 Unilever N.V. A personal cleaning composition
WO2013064633A1 (de) * 2011-11-04 2013-05-10 Amp-Therapeutics Gmbh Oncopeltus-peptidderivate als antimikrobielle peptide
FR3012811B1 (fr) * 2013-11-05 2015-12-25 Basf Beauty Care Solutions France Sas Oligopeptides et leurs utilisations
KR101851236B1 (ko) 2015-07-06 2018-04-24 김철군 동충하초 재배용 배지조성물 및 동충하초 재배방법
KR20190065916A (ko) 2017-12-04 2019-06-12 김철군 동충하초 재배용 배지조성물 및 동충하초의 재배방법
CN113226278B (zh) 2019-01-02 2023-07-21 宝洁公司 含有肽化合物和水前寺海苔胞外多糖提取物的皮肤护理组合物
KR102192471B1 (ko) * 2019-10-18 2020-12-17 주식회사 인코스팜 탈모 완화 및 모발 성장을 촉진시키는 펩타이드 및 이를 포함하는 화장료 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU68901A1 (enExample) 1973-11-30 1975-08-20
US4966848A (en) * 1988-02-08 1990-10-30 The General Hospital Corporation Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
US5830993A (en) 1995-04-10 1998-11-03 Kansas State University Research Foundation Synthetic antimicrobial peptide
US6713605B1 (en) 1996-04-10 2004-03-30 Kansas State University Research Foundation Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
DE19756377A1 (de) 1997-12-18 1999-06-24 Beiersdorf Ag Verwendung von C¶1¶¶8¶-¶3¶¶8¶-Alkylhydroxystearoylstearat zur Verstärkung der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
US6231768B1 (en) 1999-01-19 2001-05-15 Nalco Chemical Company Rheology modification of settled solids in mineral processing
FR2788777B1 (fr) 1999-01-22 2003-01-17 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la regulation des dysfonctionnements immunologiques cutanes et dans l'inflammation cutanee induits par le vieillissement ou par les u.v.
CA2368638A1 (en) * 1999-03-26 2000-10-05 Beth Israel Deaconess Medical Center Method for pr-39 peptide regulated stimulation of angiogenesis
WO2001030368A1 (en) * 1999-10-25 2001-05-03 Beth Israel Deaconess Medical Center Method for pr-39 peptide regulated stimulation of angiogenesis
EP1242107A4 (en) 1999-12-29 2004-10-06 Beth Israel Hospital METHOD FOR THE SELECTIVE INHIBITION OF THE DEGRADATION OF THE IKAPPABALPHA PROTEIN INDUCED BY THE PEPTIDE PR-39
WO2003037933A2 (de) * 2001-10-30 2003-05-08 Pentapharm Ag Dermopharmazeutisch und kosmetisch wirksame oligopeptide
JPWO2003042387A1 (ja) 2001-11-13 2005-03-10 学校法人慶應義塾 新規毛髪ケラチン付随タンパク質
FR2836042B1 (fr) * 2002-02-15 2004-04-02 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour diminuer les poches et cernes sous les yeux
BR0314558A (pt) * 2002-10-10 2005-08-09 Diversa Corp Proteases, ácidos nucléicos codificando as mesmas e processos para preparar e usar as mesmas
WO2006042661A2 (en) 2004-10-18 2006-04-27 Cognis France S.A.S Oligopeptides and their use in cosmetics

Also Published As

Publication number Publication date
US8044028B2 (en) 2011-10-25
EP1802655B1 (en) 2013-07-24
WO2006042661A3 (en) 2006-07-27
JP5159311B2 (ja) 2013-03-06
WO2006042661A2 (en) 2006-04-27
EP1802655A2 (en) 2007-07-04
US20100137560A1 (en) 2010-06-03
KR101264441B1 (ko) 2013-05-14
US20120172308A1 (en) 2012-07-05
JP2008517009A (ja) 2008-05-22
KR20070065882A (ko) 2007-06-25

Similar Documents

Publication Publication Date Title
US20120172308A1 (en) Oligopeptides And Their Use In Cosmetics
US8815814B2 (en) Cosmetic composition containing oligopeptides
US8399415B2 (en) Oligopeptides and cosmetic compositions containing the oligopeptides
ES2334102T3 (es) Uso de extractos del hongo grifola frondosa.
US20100183527A1 (en) Cosmetic Compositions Comprising Sclareolide and Hesperidin Methyl Chalcone
ES2347955T3 (es) Utilización de un extracto de la planta vigna aconitifolia en una composición cosmética y/o farmacéutica dermatológica.
US20240041743A1 (en) Synergistic tetrapeptide combination
US20030068364A1 (en) Pro-liposomal encapsulated preparations (iv)
CN113264984A (zh) 肽化合物、包含它们的组合物和所述化合物，特别是化妆品的用途
KR101240695B1 (ko) Ｐｔｈ 단편 함유 화장품 제제
JP2003531844A (ja) 植物Ａｒｇａｎｉａｓｐｉｎｏｓａの抽出物を含有する化粧品製剤および／または医薬製剤
US20030170298A1 (en) Proliposomal encapsulated preparations
ES2250188T3 (es) Preparados cosmeticos y/o farmaceuticos.
FR3012811A1 (fr) Oligopeptides et leurs utilisations